share_log

Maxim Group Initiates Coverage On Heart Test Laboratories With Buy Rating, Announces Price Target of $8

Maxim Group Initiates Coverage On Heart Test Laboratories With Buy Rating, Announces Price Target of $8

Maxim Group以买入评级启动对心脏测试实验室的保险,宣布目标股价为8美元
Benzinga Real-time News ·  2022/11/09 09:06

Maxim Group analyst Allen Klee initiates coverage on Heart Test Laboratories (NASDAQ:HSCS) with a Buy rating and announces Price Target of $8.

Maxim集团分析师艾伦·克利以买入评级开始对心脏测试实验室(纳斯达克股票代码:HSCS)进行报道,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发